Caricamento...
Beyond HER2: recent advances and future directions in targeted therapies in esophagogastric cancers
Esophagogastric cancers (EGCa) are a leading cause of cancer related mortality worldwide. It has been recognized that they represent heterogenous diseases based on histology and anatomy. However, it is also increasingly evident that these are diverse malignancies based on genetic alterations, and th...
Salvato in:
| Pubblicato in: | J Gastrointest Oncol |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056259/ https://ncbi.nlm.nih.gov/pubmed/27747090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.08.13 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|